Leading and specialty CROs across the industry use Rave with their clients. Medidata's industry-leading Services Partner program helps CROs bring the best technology to their clinical development activities.
(Please scroll down to access white papers, case studies and data sheets.)
Cell and Gene Therapies have demonstrated real promise as they move into the clinical trial phase for a variety of life changing and deadly diseases. The results of these studies and their potential impact to patients, their loved ones and the industry as a whole are almost incalculable, which makes securing the supply chain mission critical — though not easily accomplished. What makes World Courier so essential for Cell and Gene Therapy logistics is our understanding and our ability to address these critical issues.
Our team has extensive experience developing complex randomization schemes, including dynamic allocation (adaptive randomization).
Prancer supports central randomization, site blocked randomization, multiple strata, dynamically blocked to strata, dynamically blocked to strata and site as well as multiple randomizations.
Led by industry safety expert, Annette Stemhagen, DrPH, FISPE, UBC’s Risk Management, Registries & Epidemiology team brings unmatched passion and commitment to your product and your reputation.
For over two decades, SynteractHCR has successfully managed over 3400 projects in multiple therapeutic areas and are proud to have supported numerous global product approvals. In addition, our specialized expertise in working with emerging pharma, biotech and device companies helps us guide them through the clinical development process.
Successfully manage your clinical development programs.
Our security and governance capabilities, including ISO 207001 certification, FDA 21 CFR Part 11 validation and HIPAA compliance, were designed to protect high-value information for the most-regulated industries.
If you use goBalto Activate for study startup, you have a wealth of data for sites, study countries, and study document and submission activities that you can use in reports and analytics.
Advances in technology have allowed risk-based monitoring to become more frequently implemented in clinical trials. This market research report explores the impact technology has had on the implementation of RBM on clinical trial operations as experienced by site personnel.
PCI provides extensive experience working with many Interactive Response Technology (IRT) solution providers.
Why is Express EDC used by Sponsors and CROs to build studies and capture data for thousands of clinical studies worldwide? To sum it up: You get more. Do more. See deeper into your studies and manage study data, not just capture it — all within a single, powerful solution that puts everything at your fingertips. Ideal for any clinical trial regardless of size, phase or complexity, Express is the foundation of many leading research programs and is used on thousands of studies worldwide.